Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial?
about
St. Gallen/Vienna 2015: A Brief Summary of the Consensus DiscussionModern therapeutic concepts of early breast cancer.The recurrence frequency of breast cancer and its prognostic factors in Iranian patients.The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer.Optimal duration of adjuvant endocrine therapy: how to apply the newest data.
P2860
Late recurrences in early breast cancer: for whom and how long is endocrine therapy beneficial?
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Late recurrences in early brea ...... endocrine therapy beneficial?
@ast
Late recurrences in early brea ...... endocrine therapy beneficial?
@en
type
label
Late recurrences in early brea ...... endocrine therapy beneficial?
@ast
Late recurrences in early brea ...... endocrine therapy beneficial?
@en
prefLabel
Late recurrences in early brea ...... endocrine therapy beneficial?
@ast
Late recurrences in early brea ...... endocrine therapy beneficial?
@en
P2093
P2860
P356
P1433
P1476
Late recurrences in early brea ...... endocrine therapy beneficial?
@en
P2093
Martin Filipits
Michael Knauer
Peter Dubsky
P2860
P304
P356
10.1159/000362482
P577
2014-05-01T00:00:00Z